The FDA issued new guidance for sponsors of drugs designed to treat hay fever as well as other cold-like symptoms that aren’t caused by allergies. In a pair of final guidances released Wednesday, the agency urges drug sponsors to focus on real-world settings when trying to determine ideal doses.
Source: Drug Industry Daily